• Explore /
  • Poster
  • / SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy.

SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy.

Abstract Poster

Authors

null

Karyn A. Goodman

Icahn School of Medicine at Mount Sinai, New York, NY

Karyn A. Goodman , Rui-hua Xu , Ian Chau , Ming Huang Chen , Byoung Chul Cho , Manish A. Shah , Kei Muro , Yifan Wang , Mari Ichimaru , Qingyuan Liu , Luhua Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04543617

DOI

10.1200/JCO.2022.40.4_suppl.TPS374

Abstract #

TPS374

Poster Bd #

M7

Abstract Disclosures

Similar Posters

First Author: Luhua Wang

First Author: Mustafa Özgüroğlu

First Author: Xue Meng

First Author: Nicoletta Colombo